Catalyst Watch: Tariff repercussions, Tesla deliveries, the jobs report, and Microsoft turns 50
Get ahead with Seeking Alpha’s Catalyst Watch. Explore next week's events like IPOs, earnings, and Fed updates poised to ...
Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?
Alcon (ALC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...
Nevro Corp. (NYSE:NVRO) Receives Consensus Recommendation of “Reduce” from Brokerages
Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nevro Corp (NVRO), Globus Medical (GMED) and Vertex Pharmaceuticals (VRTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus Medical (GMED – Research Report) a ...
Wall Street Journal16d
Nevro Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
ETF Daily News24d
Nevro (NYSE:NVRO) Coverage Initiated by Analysts at StockNews.com
Nevro stock opened at $5.79 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.76 and a current ratio of 5.02. The firm has a 50 day moving average price of $4.89 and ...
Nasdaq25d
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
Nevro (NVRO) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.15 per share a year ago. These figures are ...